BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RC1416 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RC1416\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07403487-1553@assetmemo.bio
DTSTAMP:20261121T005556Z
DTSTART;VALUE=DATE:20271025
DTEND;VALUE=DATE:20271026
SUMMARY:RC1416: Phase 2 readout est. (NCT07403487)
DESCRIPTION:RC1416\, phase 2\, Asthma.\nStudy: Phase II Trial of RC1416 Inj
 ection in Asthma\nEstimated primary completion: 25 October 2027. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/rc1416#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT07403487
URL:https://assetmemo.bio/drug/rc1416#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07402551-1553@assetmemo.bio
DTSTAMP:20261121T005556Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:RC1416: Phase 2 readout est. (NCT07402551)
DESCRIPTION:RC1416\, phase 2\, Chronic Obstructive Pulmonary Disease.\nStud
 y: Phase II Study of RC1416 Injection in COPD\nEstimated primary completio
 n: 31 May 2028. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/rc141
 6#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07
 402551
URL:https://assetmemo.bio/drug/rc1416#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
